Embed this press release by copying the code below:
FDA Lifts Clinical Hold of Pluristem Therapeutics Inc's Phase II Intermittent Claudication Study
FDA Lifts Clinical Hold of Pluristem Therapeutics Inc's Phase II Intermittent Claudication Study